Arvinas (ARVN) Revenue Growth (3y) (2020 - 2026)
Arvinas (ARVN) Revenue Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Revenue Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
0.73% |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
122.97% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
7.94% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Arvinas |
492.16 Mn |
-122.74 Mn |
- |
-21.70% |
| Date | Value |
|---|
| Mar 31, 2026 |
-21.70% |
| Dec 31, 2025 |
-36.89% |
| Sep 30, 2025 |
8.07% |
| Jun 30, 2025 |
-12.81% |
| Mar 31, 2025 |
92.42% |
| Dec 31, 2024 |
21.26% |
| Sep 30, 2024 |
122.47% |
| Jun 30, 2024 |
140.49% |
| Mar 31, 2024 |
66.31% |
| Dec 31, 2023 |
-106.64% |
| Sep 30, 2023 |
65.76% |
| Jun 30, 2023 |
111.66% |
| Mar 31, 2023 |
73.34% |
| Dec 31, 2022 |
97.68% |
| Sep 30, 2022 |
3.38% |
| Jun 30, 2022 |
103.40% |
| Mar 31, 2022 |
87.56% |
| Dec 31, 2021 |
112.91% |
| Sep 30, 2021 |
40.19% |
| Jun 30, 2021 |
17.39% |
